 |
|
|
|||||||||
|
StrategyDiaKine Therapeutics’ strategy is to leverage our medical, scientific and management experience and thus, drive our products to market as reliably, rapidly and efficiently as possible. We plan to generate depth and value through product development that addresses the unmet medical needs of people with diabetes and complications brought on by this devastating disease. Concurrently, we will solidify the Company’s financial position while building the necessary infrastructure to succeed as a global biopharmaceutical player.
|
||||||||||
|
|
|
|
|
||||||||
|
©2006 DiaKine Therapeutics. All rights reserved.
|
|||||||||||
